The common sense model in Raynaud’s phenomenon: do illness perceptions account for variance in symptom severity and quality of life?
Open Access
- 30 September 2024
- journal article
- research article
- Published by Cambridge University Press (CUP) in The Cognitive Behaviour Therapist
- Vol. 17, e24
Abstract
People with Raynaud’s phenomenon (RP) experience poorer mental health and quality of life than the general population, and there is limited evidence for treatment options in RP. The Common Sense Model of illness representations (CSM) is a well-established theoretical model, which has not yet been robustly investigated in RP, but may provide potential avenues for psychological interventions with the ability to explore perceptions and beliefs, such as cognitive behavioural therapy (CBT). The study aims were to investigate illness perceptions and examine the relationship between illness perceptions and symptom severity and quality of life in RP to explore a theoretical basis for potential treatment avenues. A cross-sectional online questionnaire design was employed and 169 adults with RP (primary or secondary) were analysed. Illness perceptions significantly differed between primary and secondary RP types on all but one domain (p < .05). Hierarchical multiple regressions indicated that illness perception subscales made a significant unique contribution to the models explaining 65% variance in symptom severity (R2 = .65, p < .001) and 30% variance in quality of life (R2 = .30, p < .001). This novel study provides preliminary evidence regarding the applicability of the CSM to RP in a clinically meaningful way. CBT, which can specifically target illness perceptions within a wider psychological formulation, may be helpful for individuals with RP who are experiencing psychological distress in relation to symptom severity. Further work is needed to develop outcome measures specific to RP and tailor interventions to manage distress and impaired quality of life. Key learning aims: (1) The Common Sense Model is applicable and relevant to Raynaud’s phenomenon (RP) and there are important differences between illness perceptions in those with primary and secondary RP subtypes. (2) Findings show that illness-specific cognitions make a significant contribution to the variance in symptom severity and quality of life in those with both subtypes of RP, which has notable implications for the assessment, formulation and treatment of psychological difficulties in RP. (3) This offers a basis for further replication and development and adaptation of an intervention for this group, drawing on the evidence base for long-term conditions.Keywords
This publication has 60 references indexed in Scilit:
- Illness perceptions, risk perceptions and worries in patients with early systemic sclerosis: A focus group studyMusculoskeletal Care, 2020
- Factors associated with quality of life in systemic sclerosis: a cross-sectional studyQuality of Life Research, 2019
- Raynaud’s phenomenon—an update on diagnosis, classification and managementClinical Rheumatology, 2019
- Multinational Qualitative Research Study Exploring the Patient Experience of Raynaud's Phenomenon in Systemic SclerosisArthritis Care & Research, 2017
- Illness perceptions mediate the relationship between bowel symptom severity and health-related quality of life in IBS patientsQuality of Life Research, 2015
- The Association of Illness Perceptions with Physical and Mental Health in Systemic Sclerosis Patients: An Exploratory StudyMusculoskeletal Care, 2011
- Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS‐G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ‐S)Arthritis Care & Research, 2011
- Reproducibility of the Bath Ankylosing Spondylitis Indices of disease activity (BASDAI), functional status (BASFI) and overall well-being (BAS-G) in anti-tumour necrosis factor-treated spondyloarthropathy patientsClinical Rheumatology, 2010
- Psychometric properties of the Depression Anxiety and Stress Scale-21 in older primary care patientsJournal of Affective Disorders, 2008
- Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenonArthritis & Rheumatism, 2002